This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Analysts Offer Insights on Healthcare Companies: Definitive Healthcare Corp (DH), ICU Medical (ICUI) and Brookdale Senior Living (BKD)

Tipranks - Tipranks - Sat May 9, 7:08AM CDT

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Definitive Healthcare Corp (DH), ICU Medical (ICUI) and Brookdale Senior Living (BKD).

Claim 55% Off TipRanks

Definitive Healthcare Corp (DH)

Needham analyst Ryan MacDonald reiterated a Hold rating on Definitive Healthcare Corp today. The company’s shares closed last Thursday at $0.92.

According to TipRanks.com, MacDonald has 0 stars on 0-5 stars ranking scale with an average return of -11.3% and a 35.5% success rate. MacDonald covers the Technology sector, focusing on stocks such as ODDITY Tech Ltd. Class A, Waystar Holding Corp., and Liveperson. ;'>

Currently, the analyst consensus on Definitive Healthcare Corp is a Hold with an average price target of $2.63, which is a 179.8% upside from current levels. In a report issued on April 30, TipRanks – xAI also reiterated a Hold rating on the stock with a $0.92 price target.

See today’s best-performing stocks on TipRanks >>

ICU Medical (ICUI)

Needham analyst Michael Matson maintained a Hold rating on ICU Medical today. The company’s shares closed last Thursday at $123.07.

According to TipRanks.com, Matson is a 2-star analyst with an average return of 0.5% and a 42.7% success rate. Matson covers the Healthcare sector, focusing on stocks such as Insight Molecular Diagnostics, Establishment Labs Holdings, and Zimmer Biomet Holdings. ;'>

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for ICU Medical with a $163.50 average price target, implying a 34.9% upside from current levels. In a report issued on April 24, TipRanks – xAI also reiterated a Hold rating on the stock with a $130.00 price target.

Brookdale Senior Living (BKD)

Stephens analyst Kyle Evans maintained a Buy rating on Brookdale Senior Living today and set a price target of $18.00. The company’s shares closed last Thursday at $13.56.

According to TipRanks.com, Evans is ranked #2102 out of 12242 analysts.

Brookdale Senior Living has an analyst consensus of Strong Buy, with a price target consensus of $19.00, implying a 43.6% upside from current levels. In a report released yesterday, Barclays also maintained a Buy rating on the stock with a $18.00 price target.

Read More on DH:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).